Clinical Trial Update: R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating R-Flurbiprofen for localized prostate cancer at risk of recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• R-Flurbiprofen (R-flurbiprofen (R-enantiomer of flurbiprofen))

Snippet

Sponsor: Myrexis Inc. | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN